- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Emergent Connect Adds AI-Driven Work List to Its Workflow Solutions
Priority Work List could enhance analysis and reduce false negatives.
Cloud-based software solution company Emergent Connect, LLC, has launched Priority Work List, an artificial intelligence (AI)-driven addition to its existing radiology workflow tools.
As a completely cloud-based platform, Priority Work List offers radiologists a variety of AI algorithms approved by the U.S. Food and Drug Administration and deep learning that can read images captured on several modalities. The algorithms have been trained on thousands of images from Emergent Connect’s databases.
According to company information, the Work List helps prioritize the workflow to reduce cost and turnaround times to below 60 minutes, as well as, enhance analysis and, potentially, eliminate false negatives. The intent, based on a company statement, is to identify, diagnose, create a prognosis, and suggest possible treatments.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.
